Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
批准号:
10387219
负责人:
Mercedes Gonzalez-Juarrero
金额:
$51.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-17 至 2026-08-31
关键词:
AcademiaAddressAffectAmino AcidsAmino SugarsAnabolismAttentionBacillusBiochemicalBiochemistryBiocideBiologicalBiological MarkersC3HeB/FeJ MouseCOVID-19Carbohydrate ChemistryCarbohydratesCause of DeathCell WallCell surfaceCellsChargeColoradoDendritic CellsDevelopmentEnsureEnvironmentGalactosamineGenerationsGeneticGenus MycobacteriumGlycobiologyGram-Positive BacteriaGranulomaHost DefenseInfectionInfectious AgentInstitutesKnock-outKnowledgeLaboratoriesLeadLipopolysaccharidesLung infectionsMediatingMembraneModelingModificationMusMycobacterium InfectionsMycobacterium tuberculosisNatural ImmunityNecrosisPathogenesisPathogenicityPathologyPatientsPhysiologicalPhysiological ProcessesPhysiologyPlayPolysaccharidesProkaryotic CellsResearch PersonnelResistanceRoleStressStructureSurface PropertiesTaiwanTestingTherapeuticUniversitiesVirulenceWheatacyl groupadaptive immunityarabinogalactancell envelopedesignenvironmental stressorimmunopathologyinnovationinorganic phosphatelipoarabinomannanlipomannanlipoteichoic acidmacrophagemicroorganismmultidisciplinarymutantmycobacterialpathogenphysical propertyprophylacticresponsesugarthiosugartranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The covalent modification of prokaryotic cell envelope glycans, namely lipopolysaccharide (LPS) and
(lipo)teichoic acids, with discrete substituents such as sugars, amino acids, phosphates or acyl groups, is a
well-known strategy used by Gram-negative and Gram-positive bacteria to modulate their cell surface
properties, the way they interact with their environment, their resistance to biocides and host defenses, and
pathogenicity. Although evidence exists that Mycobacterium tuberculosis (Mtb) similarly decorates its major
cell envelope glycans, arabinogalactan (AG) and lipoarabinomannan (LAM), with various tailoring substituents,
little is known of their biological significance. The discovery by our laboratories of the biosynthetic machineries
responsible for the synthesis and transfer of these discrete motifs to AG and LAM, and the generation of the
first Mtb knock-out mutants deficient in their biosynthesis have opened the way to studies aimed at
understanding the function of these motifs in the physiology and immunopathogenesis of Mtb. We
hypothesize that Mtb has evolved to modify its cell-envelope glycans with a distinct array of
strategically placed substituents to promote its survival in the host environment. Accordingly, a
multidisciplinary team of investigators with complementary expertise in mycobacterial cell envelope genetics
and glycobiology, TB immunopathogenesis, and carbohydrate chemistry here proposes to investigate how
simple (amino/thio)sugars or other charged groups strategically placed within the Mtb cell envelope landscape
affect not only the physiology of this microorganism (Aim 1), but also the course of pulmonary infection,
pathology and development of innate and adaptive immunity in infected C3HeB/FeJ mice (Aim 2), and the
interactions of Mtb with host macrophages and dendritic cells thereby promoting survival within the host (Aim
3). Ultimately, these studies are expected to lead to significant new knowledge about the biological significance
of understudied aspects of the unique cell wall of mycobacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10312329
-
项目类别:
-
资助金额:$83.64万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10437923
-
项目类别:
-
资助金额:$79.41万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
-
批准号:10490882
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
-
批准号:10685409
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10626051
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Vectra Polaris microscope imaging system
-
批准号:10175807
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Minipigs as animal model for infant TB and vaccine efficacy
-
批准号:8810222
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
siRNA-nanoparticles host targeted immunotherapy for tuberculosis
-
批准号:8638299
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Minipigs as animal model for infant TB and vaccine efficacy
-
批准号:8684285
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Host targeted immunotherapy for TB treatment
-
批准号:8487363
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2012
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Host targeted immunotherapy for TB treatment
-
批准号:8391404
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2012
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Zeiss LSM 510 Laser Scanning Microscope
-
批准号:7217125
-
项目类别:
-
资助金额:$43.74万
-
财政年份:2007
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
海外基金